Cecily Jenkins, PhD

Title(s)Associate Professor of Clinical Neurology
SchoolKeck School of Medicine of Usc
AddressATR 9860 Mesa Rim Road
Health Sciences Campus
San Diego CA 92121
Phone+1 858 964 1453
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Clark University, Worcester, MAPhD10/1999Clinical Psychology
    Carleton College, Northfield, MNBA06/1984Bio-Psychology

    Collapse Overview 
    Collapse Overview
    Cecily Jenkins, PhD is Associate Professor of Clinical Neurology in USC’s Alzheimer’s Therapeutic Research Institute (ATRI). As a licensed clinical neuropsychologist with expertise in cognitive assessment of older adults, her professional trajectory found focus in neurodegenerative conditions of aging for the past three decades. In the University of California, San Diego Department of Neurosciences Dr. Jenkins established and directed the Memory in Aging Project (MAP) and Memory Screening initiatives within the Shiley-Marcos Alzheimer’s Disease Research Center. There she led efforts to strengthen academic-public research partnerships in the San Diego community through outreach programs offering public education about memory research, brief cognitive assessment for older adults concerned about memory decline, and through facilitation of support programs for patients with Alzheimer’s Disease and their care-partners.

    In her current position as Director of Neuropsychology at ATRI Dr. Jenkins plays a key role in the conduct of ATRI and the NIH funded Alzheimer’s Clinical Trials Consortium (ACTC). She manages the ACTC Clinical Outcome Instruments Unit, a team of internationally recognized experts advising ATRI and ACTC affiliated trialists and their academic/industry partners in selection of cognitive and clinical scales appropriate to the research questions. The team also provides operational guidance to promote clean data capture. Dr. Jenkins’ Neuropsychology team enforces rigorous training and certification standards for trial site personnel conducting cognitive assessments when these are primary study outcomes. She also directs expert quality review of collected data in select trials of disease-modifying interventions for pre-clinical Alzheimer’s Disease.

    Collapse ORNG Applications 
    Collapse Featured Publications

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Safety, Efficacy, and Feasibility of Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer Disease Dementia: A Randomized Clinical Trial. JAMA Neurol. 2020 09 01; 77(9):1099-1109. Craft S, Raman R, Chow TW, Rafii MS, Sun CK, Rissman RA, Donohue MC, Brewer JB, Jenkins C, Harless K, Gessert D, Aisen PS. PMID: 32568367; PMCID: PMC7309571.
      View in: PubMed   Mentions: 141     Fields:    Translation:Humans
    2. Community memory screening as a strategy for recruiting older adults into Alzheimer's disease research. Alzheimers Res Ther. 2020 06 30; 12(1):78. Peavy GM, Jenkins CW, Little EA, Gigliotti C, Calcetas A, Edland SD, Brewer JB, Galasko D, Salmon DP. PMID: 32605603; PMCID: PMC7325657.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    3. Detection of Rater Errors on Cognitive Instruments in a Clinical Trial Setting. J Prev Alzheimers Dis. 2018; 5(3):188-196. Connor DJ, Jenkins CW, Carpenter D, Crean R, Perera P. PMID: 29972212.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    4. Temporal sequence learning in healthy aging and amnestic mild cognitive impairment. Exp Aging Res. 2013; 39(4):371-81. Pirogovsky E, Holden HM, Jenkins C, Peavy GM, Salmon DP, Galasko DR, Gilbert PE. PMID: 23875836; PMCID: PMC3736698.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    5. When help becomes a hindrance: mental health referral systems as barriers to care for primary care physicians treating patients with Alzheimer's disease. Am J Geriatr Psychiatry. 2010 Jul; 18(7):576-85. Franz CE, Barker JC, Kim K, Flores Y, Jenkins C, Kravitz RL, Hinton L. PMID: 20593538; PMCID: PMC2955197.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    6. Deterioration of visual-perceptual organization ability in Alzheimer's disease. Cortex. 2007 Oct; 43(7):967-75. Paxton JL, Peavy GM, Jenkins C, Rice VA, Heindel WC, Salmon DP. PMID: 17941353.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    7. Longitudinal MRI findings from the vitamin E and donepezil treatment study for MCI. Neurobiol Aging. 2008 Sep; 29(9):1285-95. Jack CR, Petersen RC, Grundman M, Jin S, Gamst A, Ward CP, Sencakova D, Doody RS, Thal LJ, Members of the Alzheimer's Disease Cooperative Study (ADCS). PMID: 17452062; PMCID: PMC2768818.
      View in: PubMed   Mentions: 64     Fields:    Translation:Humans
    8. Effectiveness of support groups for people with mild to moderate Alzheimer's disease: an evaluative survey. Am J Alzheimers Dis Other Demen. 2007 Feb-Mar; 22(1):14-9. Snyder L, Jenkins C, Joosten L. PMID: 17533997; PMCID: PMC10697201.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    9. Identification of Alzheimer disease risk by functional magnetic resonance imaging. Arch Neurol. 2005 Dec; 62(12):1881-8. Fleisher AS, Houston WS, Eyler LT, Frye S, Jenkins C, Thal LJ, Bondi MW. PMID: 16344346.
      View in: PubMed   Mentions: 47     Fields:    Translation:HumansCells
    10. Incidence of and risk factors for hallucinations and delusions in patients with probable AD. Neurology. 2000 May 23; 54(10):1965-71. Paulsen JS, Salmon DP, Thal LJ, Romero R, Weisstein-Jenkins C, Galasko D, Hofstetter CR, Thomas R, Grant I, Jeste DV. PMID: 10822438.
      View in: PubMed   Mentions: 66     Fields:    Translation:Humans
    11. The neuropsychology of aging. Current Opinion in Psychiatry. 1994; 7:347-353. Paulsen, JS, Weisstein, CC & Heaton, RK .
    12. Structural organization of discourse production following right hemisphere damage . Journal of Clinical and Experimental Neuropsychology. 1992; 14(1):40. Glosser, G, Deser, T & Weisstein, C .
    13. Freebase cocaine and memory. Comprehensive Psychiatry. 1990; 31(4):369-375. Manschreck, T C, Schneyer, ML, Weisstein, CC, Laughery, J, Rosenthal, J, Celada, T & Berner, J .
    14. Characteristics of freebase cocaine psychosis. The Yale Journal of Biology and Medicine . 1988; 61:115-122. Manschreck, TC, Laughery, JA, Weisstein, CC, Allen, DA, Humblestone, B, Neville, M, Podlewski, H & Mitra, N .
    15. Semantic priming in thought disordered schizophrenic patients. Schizophrenic Research. 1988; 1:61-66. Manschreck, TC, Maher, BA, Milavetz, JJ, Ames, D, Weisstein, CC & Schneyer, ML .
    16. Cloze analysis in schizophrenic speech: Scoring method and rater's education . Perceptual and Motor Skills . 1988; 67:911-918. Maher, BA, Manschreck, TC, Weisstein, CC, Schneyer, ML & Okunieff, R .
    17. Positive and Negative Symptoms of Psychosis. In P. Harvey and E. Walker (Eds.), Lawrence Erlbaum Associates: Hillsdale, New Jersey. . Thought disorder and measured features of language production in schizophrenia. 1987. Maher, BA, Manschreck, TC, Hoover, TM & Weisstein, CC .
    Cecily's Networks
    Concepts (84)
    Derived automatically from this person's publications.
    _
    Co-Authors (18)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _